Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention
In saphenous vein graft stenosis, the Percutaneous Coronary Intervention (PCI) with a Drug-Eluting Stent (DES) has been practiced progressively in comparison to Bare Metal Stent (BMS) although there is not enough compelling clinical evidence to support their use. Randomized controlled trials comparing DES versus bare-metal stents (BMS) in saphenous vein graft–percutaneous coronary intervention has been inconclusive. The analysis of mortality, major adverse cardiovascular events, target vessel revascularization, myocardial infarction, and stent thrombosis showed that there was no major difference between Drug-Eluting Stent (DES) and Bare Metal Stent (BMS).
Full Article - https://www.ahajournals.org/doi/full/10.1161/CIRCINTERVENTIONS.118.007045